Sin Nombre virus
Virus of the family Hantaviridae

The Sin Nombre virus (SNV) is a species of Orthohantavirus that is known to cause Hantavirus pulmonary syndrome (HPS) in humans. It was first identified in the southwestern United States in 1993 and is primarily carried by the deer mouse (Peromyscus maniculatus).
Discovery and Naming
The Sin Nombre virus was first recognized during an outbreak of HPS in the Four Corners region of the United States in 1993. The name "Sin Nombre," which means "without a name" in Spanish, was chosen to avoid stigmatizing the region or the people living there. The virus was initially referred to as the "Four Corners virus," but this was changed to prevent any negative association with the area.
Virology

The Sin Nombre virus is an enveloped, single-stranded, negative-sense RNA virus. It belongs to the genus Orthohantavirus within the family Hantaviridae. The virus has a tripartite genome consisting of three segments: the small (S), medium (M), and large (L) segments, which encode the nucleocapsid protein, glycoproteins, and RNA-dependent RNA polymerase, respectively.
Transmission
The primary reservoir host of the Sin Nombre virus is the deer mouse (Peromyscus maniculatus). Humans typically become infected through inhalation of aerosolized virus particles from rodent urine, droppings, or nesting materials. The virus is not transmitted from person to person.

Clinical Manifestations
In humans, infection with the Sin Nombre virus can lead to Hantavirus pulmonary syndrome, a severe respiratory disease characterized by fever, muscle aches, and fatigue, followed by rapid onset of pulmonary edema and respiratory failure. The disease has a high mortality rate, and early diagnosis and supportive care are critical for patient survival.
Prevention and Control
Preventing Sin Nombre virus infection involves minimizing contact with rodent carriers and their excreta. Measures include sealing homes to prevent rodent entry, using traps to reduce rodent populations, and practicing good hygiene when cleaning areas where rodents may have been present.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian